Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Clinical Medicine (London, England)|January 18, 2019
Hindsight bias critically impacts on clinicians' assessment of care quality in retrospective case note reviewEdward Banham-Hall, Sian Stevens
Acute Medicine|May 25, 2011
Poisoning and toxicological emergencies - current trends and practiceEdward Banham-Hall, Robert Mallinson, Nicola Trepte
The Open Rheumatology Journal|October 3, 2012
The Therapeutic Potential for PI3K Inhibitors in Autoimmune Rheumatic DiseasesEdward Banham-Hall, Menna R Clatworthy, Klaus Okkenhaug
Clinical Therapeutics|May 12, 2019
Safety, Tolerability, and Pharmacokinetics of a New Formulation of Nemiralisib Administered via a Dry Powder Inhaler to Healthy IndividualsRobert Wilson, Alison Templeton, Claudia Leemereise, et al.
Clinical Medicine (London, England)|February 5, 2021
Admission COVID-19 clinical risk assessment for guiding patient placement and diagnostic testing strategyNick K Jones, Isobel Ramsay, Elinor Moore, et al.
Journal of Clinical Pharmacology|May 15, 2026
Randomized, Placebo-Controlled, First-in-Human Study of the Safety, Tolerability, and Pharmacokinetics of Single and Repeat Oral Doses of Novel Antitubercular Drug Candidate, GSK2556286, in Healthy AdultsEmma Ilsley, Edward Banham-Hall, Tetyana Chaychenko, et al.
Trials|July 10, 2020
Repurposed immunomodulatory drugs for Covid-19 in pre-ICu patients - mulTi-Arm Therapeutic study in pre-ICu patients admitted with Covid-19 - Repurposed Drugs (TACTIC-R): A structured summary of a study protocol for a randomised controlled trialSpoorthy Kulkarni, Marie Fisk, Michalis Kostapanos, et al.
Trials|August 2, 2020
muLTi-Arm Therapeutic study in pre-ICu patients admitted with Covid-19-Experimental drugs and mechanisms (TACTIC-E): A structured summary of a study protocol for a randomized controlled trialIng Ni Lu, Spoorthy Kulkarni, Marie Fisk, et al.
Lab on a Chip|June 19, 2019
Cell sorting actuated by a microfluidic inertial vortexRobyn H Pritchard, Alexander A Zhukov, James N Fullerton, et al.
The Lancet. Respiratory Medicine|November 17, 2023
Efficacy and safety of baricitinib or ravulizumab in adult patients with severe COVID-19 (TACTIC-R): a randomised, parallel-arm, open-label, phase 4 trialFrances C Hall, Joseph Cheriyan, Andrew P Cope, et al.
Pageof 2